The differences in the activated transcriptional pathways in HCC1806 AIB1 LOW cells compared to control cells suggests that there may be significant differences in the engagement of this nuclear coactivator at the chromatin level.
← all excerpts
Depletion of the Transcriptional Coactivator Amplified in Breast Cancer 1 (AIB1) Uncovers Functionally Distinct Subpopulations in Triple-Negative Breast Cancer.
1
—
—